CytoDyn Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Employee Benefit Plan

Employee Benefit Plan	9 Months Ended
Feb. 28, 2018
Employee Benefit Plan	Note 12 – Employee Benefit Plan The Company has an employee savings plan (the “Plan”) pursuant to Section 401(k) of the Internal Revenue Code (the “Code”), covering all of its employees. The Company makes a qualified non-elective contribution of 3%, which consequently vests immediately. In addition, participants in the Plan may contribute a percentage of their compensation, but not in excess of the maximum allowed under the Code. During the three and nine months ended February 28, 2018 and 2017, the Company incurred an expense of approximately $30,200 and $51,700 and $10,800 and $29,500, respectively, for qualified non-elective contributions.

Employee Benefit Plan

9 Months Ended

Feb. 28, 2018

Note 12 – Employee Benefit Plan

The Company has an employee savings plan (the “Plan”) pursuant to Section 401(k) of the Internal Revenue Code (the “Code”), covering all of its employees. The Company makes a qualified non-elective contribution of 3%, which consequently vests immediately. In addition, participants in the Plan may contribute a percentage of their compensation, but not in excess of the maximum allowed under the Code. During the three and nine months ended February 28, 2018 and 2017, the Company incurred an expense of approximately $30,200 and $51,700 and $10,800 and $29,500, respectively, for qualified non-elective contributions.